New evidence on the management of Lewy body dementia

John Paul Taylor, Ian G. McKeith, David J. Burn, Brad F. Boeve, Daniel Weintraub, Claire Bamford, Louise M. Allan, Alan J. Thomas, John T. O'Brien

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Dementia with Lewy bodies and Parkinson's disease dementia, jointly known as Lewy body dementia, are common neurodegenerative conditions. Patients with Lewy body dementia present with a wide range of cognitive, neuropsychiatric, sleep, motor, and autonomic symptoms. Presentation varies between patients and can vary over time within an individual. Treatments can address one symptom but worsen another, which makes disease management difficult. Symptoms are often managed in isolation and by different specialists, which makes high-quality care difficult to accomplish. Clinical trials and meta-analyses now provide an evidence base for the treatment of cognitive, neuropsychiatric, and motor symptoms in patients with Lewy body dementia. Furthermore, consensus opinion from experts supports the application of treatments for related conditions, such as Parkinson's disease, for the management of common symptoms (eg, autonomic dysfunction) in patients with Lewy body dementia. However, evidence gaps remain and future clinical trials need to focus on the treatment of symptoms specific to patients with Lewy body dementia.

Original languageEnglish (US)
Pages (from-to)157-169
Number of pages13
JournalThe Lancet Neurology
Volume19
Issue number2
DOIs
StatePublished - Feb 2020

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'New evidence on the management of Lewy body dementia'. Together they form a unique fingerprint.

Cite this